Kelsey Arbogast, MD
Obstetrics & Gynecology · Tulsa, OKNPI 1831455468
Payments from drug & device makers
Across 93 payments — averaging $19.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Currax Pharmaceuticals LLC$159
- AbbVie$141
- KARL Storz Endoscopy-america$132
- Channel Medsystems, Inc.$129
- Hologic Sales And Service, LLC$114
- Astellas Pharma US Inc$109
- plus $988 from 28 others
What the payments were for
- Food & beverage$1,73298%
- Education$412%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Currax Pharmaceuticals LLC | 11 | $159 |
| AbbVie | 9 | $141 |
| KARL Storz Endoscopy-america | 2 | $132 |
| Channel Medsystems, Inc. | 1 | $129 |
| Hologic Sales And Service, LLC | 10 | $114 |
| Astellas Pharma US Inc | 6 | $109 |
| Exeltis, USA Inc. | 6 | $105 |
| Myovant Sciences Inc. | 6 | $93 |
| Pfizer | 4 | $66 |
| Smith+Nephew | 1 | $57 |
| Coopersurgical, Inc. | 3 | $55 |
| Bayer | 3 | $50 |
| Mayne Pharma Commercial LLC | 2 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Merck | 3 | $43 |
| AMAG Pharmaceuticals, Inc. | 3 | $41 |
| Novo Nordisk | 2 | $32 |
| Optumhealth Care Solutions, LLC | 1 | $30 |
| Biogen | 1 | $28 |
| Covidien LP | 2 | $28 |
| Johnson & Johnson | 1 | $26 |
| Teleflex LLC | 1 | $25 |
| Aspira Women's Health Inc | 2 | $24 |
| Evofem Biosciences, Inc. | 1 | $24 |
| Millicent US Inc | 1 | $22 |
| Organon | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Sanara Medtech Inc. | 1 | $19 |
| Minerva Surgical, Inc | 1 | $17 |
| Lupin Inc. | 1 | $17 |
| Mycovia Pharmaceuticals, Inc. | 1 | $16 |
| Duchesnay USA Incorporated | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
| Pacira Pharmaceuticals Incorporated | 1 | $12 |
How this compares
$1,774 in reported general payments places this provider in the 55th percentile of 396 obstetrics & gynecology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 11 | $1,441 |
| Estradiol | 21 | $508 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Tulsa
- Joseph NemcokTulsa$632K
- Calvin MonroeTulsa$219K
- Jay WilliamsonTulsa$130K
- Lori HubbardTulsa$41K
- Micah RelicTulsa$20K
- Bryan RoehlTulsa$15K
- Timmeni StevensTulsa$14K
- Rachel GibbsTulsa$12K
- Thomas LaneTulsa$11K
- Carlos GuevaraTulsa$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.